Top compounds associated with response to SHD


Feature Type Standardized
Nominal ANOVA
mRNA Vorinostat GDSC1000 pan-cancer AAC 0.23 2e-08
mRNA PX-12 CTRPv2 pan-cancer AAC 0.23 3e-06
mRNA AUY922 GDSC1000 pan-cancer AAC -0.21 4e-06
mRNA Docetaxel GDSC1000 pan-cancer AAC -0.19 4e-06
mRNA 17-AAG GDSC1000 pan-cancer AAC -0.19 5e-06
mRNA CHIR-99021 GDSC1000 pan-cancer AAC -0.18 2e-05
mRNA Bleomycin GDSC1000 pan-cancer AAC -0.2 3e-05
mRNA temsirolimus GDSC1000 pan-cancer AAC -0.19 4e-05
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.24 4e-05
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.23 5e-05
Download CSV